Mandate

Vinge advises People Ventures in conjunction with an investment in Leia Health

December 21, 2022 Life Sciences & Health

Vinge has advised the Danish VC fund People Ventures in conjunction with its investment in Leia Health, which has developed an app designed to map physical and mental health for postpartum women.

Leia Health has added MSEK 14 in its latest investment round and, in addition to People Ventures, Norrsken and Unconventional Ventures are the main investors.

Vinge’s team primarily consisted of  Johan Winnerblad, Eléonore Friberg, Jonna Skog, Ebba Nyberg and Karolina Fuhrman.

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025